Surface modification is opening new perspectives in flow diversion, particularly for patients in whom dual antiplatelet therapy (DAPT) may be challenging. In this LINNC Online webinar, Laurent Spelle, Laurent Pierot, Markus Holtmannspötter and Jean-Christophe Gentric review the latest evidence supporting the use of a surface-modified flow diverter, discuss real-world clinical applications of HPC technology, and explore how antiplatelet management may evolve in the future.
Laurent
Spelle
Paris,
France
Moderator
Markus Holtmannspotter
Nürnberg,
Germany
Speaker
Laurent
Pierot
Reims,
France
Speaker
Jean-Christophe Gentric
Brest,
France
Speaker
This program is supported by